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Background: Gait impairment represents one of the most common and disabling symptom of multiple sclerosis.
Quantification of the gait is an important aspect of clinical trials. In order to identify which temporal or spatial
parameters of gait could be used as outcome measures in interventional studies of patients with different levels of
disability, we evaluated characteristics of these parameters in MS patients across the whole spectrum of mobility
from EDSS 0 to 6.5.
Methods: This is a cross-sectional study of spatial and temporal parameters of gait at self selected speed and at fast
speed of walking in 284 patients with multiple sclerosis (108 men, mean age 38 years ± SD 10.8 years, range 18–64)
divided into seven levels of disability (EDSS 0 to 1.5, EDSS 2.0 to 2.5, EDSS 3.0 to 3.5, EDSS 4.0 to 4.5, EDSS 5.0 to 5.5,
EDSS 6.0, EDSS 6.5).
Results: The velocity of gait decreases with increasing EDSS levels. Hovewer, the spatio-temporal parameters of gait
that are involved in this process differ across the EDSS levels. The step length is decreased at higher EDSS levels up
to the EDSS 6.0, but was not different between EDSS 6.0 and 6.5. The step time is significantly longer at EDSS 6.0
and 6.5, while the step length remains the same at those levels. The increase in percentage of double support time
becomes statistically significant at EDSS 3.0-3.5 and continues to increase until EDSS 6.5. Variability of step time, step
length or step width did not show significant difference between studied EDSS levels.
Conclusions: There is no single spatio-temporal parameter of gait (other than velocity of gait) that would show
significant differences among all levels of EDSS. The step length reflects shortening of steps at lower EDSS levels (2.0 to
6.0), and percentage of double support time better reflects changes at higher EDSS levels 3.0 – 6.5. Gait variability is
not associated with disability in MS and therefore would not be a suitable outcome measure. These observations have
to be considered when designing gait experiments with temporal and spatial parameters of gait as outcomes.
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Over 75% of multiple sclerosis (MS) patients experience
difficulty in walking [1]. Gait impairment can occur in
all stages of MS and represents one of the most common
and disabling symptom of this disease [2,3]. Quantifying
impairment of walking is important when assessing new
interventions to treat MS. The expanded disability scale* Correspondence: janaprei.lizr@gmail.com
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article, unless otherwise stated.score (EDSS) is the most common measure of disability
used in multiple sclerosis studies, and although it is
driven in part by ability to walk, it is limited in its sensi-
tivity to measure gait impairment [4,5]. Other methods
that have been validated to quantify ability to walk in
MS patients, such as the 25 foot walk test (25FWT), two
minute walk test, or patient reported Multiple Sclerosis
Walking Scale (MSWS-12), do not allow assessment of
the gait cycle [6,7]. It has been established that patients
with MS have significantly different parameters of gait
cycle when compared with healthy controls.ioMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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in distance and speed of walking [8-11], but MS patients
also have decreased stride length and limited range of
ankle, knee and hip motion [10,11]. Prior studies investi-
gating specifically spatial and temporal parameters of
gait have reported decrease in velocity, cadence, step
length, and increased step time in MS patients [2,8,12].
Martin et al. has shown also a trend towards increase in
double support time in MS patients in comparison with
normal controls [3]. Current studies provide an insight
into gait changes in MS but do not provide enough of
data to characterize gait cycle abnormalities at all levels
of disability. In order to choose, which temporal or
spatial parameters of gait are applicable as outcome
measures at different levels of disability, we evaluated
characteristics of these parameters in MS patients across
the whole spectrum of mobility from EDSS 0 to 6.5.Methods
Subjects
The study group in this observational cross-sectional
study consists of 284 patients (108 men (38%)) with
multiple sclerosis (mean age 38.9 years ± standard devi-
ation (SD) 10.8 years, range 18–64) (Table 1). Consecu-
tive patients whether treated or untreated were invited
to participate in the study during the regular outpatient
visits at the multiple sclerosis clinic affiliated with an aca-
demic institution. Patients with acute MS relapse, ortho-
paedic problems, or a vision problem severe enough to
affect walking were excluded. EDSS scoring was per-
formed by an MS specialist.Table 1 Patients characteristics across EDSS levels
EDSS 0-1.5 2.0-2.5 3
Number of subjects N 62 71 4
Female % 64 55 7
Age Mean ± SD 38.5 ± 9.3 34.1 ± 8.5 3
Range 18–57 20–58 2
Leg length (cm) Mean ± SD 89.0 ± 5.3 90.0 ± 5.7 8
Range 79–102 78–105 7
Disease duration (years) Mean ± SD 7.5 ± 4.9 8.1 ± 5.9 1
Range 1–20 1–27 2
Pyramidal subscore Mean ± SD 0.77 ± 0.13 1.61 ± 0.52 2
Range 0–1 0–2 1
Cerebellar subscore Mean ± SD 0.13 ± 0.34 0.40 ± 0.60 1
Range 0–1 0–2 0
Brainstem subscore Mean ± SD 0.07 ± 0.25 0.28 ± 0.56 0
Range 0–1 0–2 0
Sensory subscore Mean ± SD 0.56 ± 0.50 1.46 ± 0.63 1
Range 0–1 0–2 1Ethic statement: The study procedures were approved
by the institutional ethics committee of the General
University Hospital and patients provided written in-
formed consent.
Gait analyses
The GAITRite® instrument (CIR systems Inc., Sparta,
NJ) used to capture parameters of gait is a 16 feet
(4.88 m) long carpet with pressure sensors that auto-
mates measurement of spatial (distance) and temporal
(timing) characteristics of gait [13-15]. We tested gait at
two different speeds. Patients were first instructed to
walk two times the length of the carpet in their regular,
self selected speed (SW), and then were asked to walk
two times the length of the carpet as fast as they can
(FW). Patients started from a standing position at the
beginning of the carpet and walked without shoes (un-
less they used an ankle foot orthosis) without stopping
past the end of the instrument.
Patients were divided into seven levels of disability
based on the Kurtzke Expanded Disability Scale (EDSS)
score [4]. The EDSS is not a continuous scale. The steps
at the lower end of the scale, such as EDSS 1.0 to 3.5 are
calculated as a composite score of seven functional sys-
tems (pyramidal, cerebellar, brainstem, sensory, bowel
and bladder, visual and cerebral score). The scores at
and above 4.0 are determined mostly by a maximal dis-
tance reached without support (4.0 = 500 m, 4.5 = 300 m,
5.0 = 200 m and 5.5 = 100 m). The EDSS 6.0 is primarily
defined by a need of unilateral aid for walking of at least
100 m and the EDSS level 6.5 is defined by a need of bi-
lateral walking aid. As the half step on EDSS scale at.0-3.5 4.0-4.5 5.0-5.5 6 6.5
3 43 20 31 14
6 67 75 45 43
8.7 ± 9.1 40.2 ± 7.6 51.6 ± 9.7 46.9 ± 9.1 49.0 ± 12.9
4–61 24–60 34–64 23–64 30–64
9.0 ± 6.0 90.0 ± 4.9 89.0 ± 4.1 90.0 ± 6.0 90.0 ± 5.2
8–102 79–102 82–98 78–102 83–98
0.5 ± 6.8 14.3 ± 5.9 21.9 ± 10.9 21.7 ± 8.6 18.9 ± 10.5
–31 2–33 7–45 3–37 2–39
.30 ± 1.26 2.87 ± 0.35 3.15 ± 0.37 3.43 ± 0.57 3.40 ± 0.51
–3 2–3 3–4 2–4 3–4
.26 ± 0.88 1.86 ± 0.68 1.75 ± 0.55 1.93 ± 0.64 2.27 ± 0.96
–3 0–3 1–3 0–3 0–4
.44 ± 0.77 1.00 ± 1.05 0.90 ± 0.91 0.90 ± 1.16 1.53 ± 1.25
–3 0–3 0–3 0–3 0–3
.91 ± 0.57 2.30 ± 0.74 2.35 ± 0.88 2.43 ± 0.86 2.47 ± 0.64
–3 0–4 1–4 0–4 1–3
Table 2 Definition of outcome measures
Outcome Description
Step length Distance from a point of the ground contact of
one foot to the point of the ground contact of
the other foot, i.e. left to right foot and right to
left foot.
Step time Period of time taken for one step.
Percentage of double
support time
A proportion of double support time from the
gait cycle. Double support time is a period of
time when both feet are in contact with the
ground. It occurs twice in the gait cycle, at the
beginning and at the end of the stance phase.
Base width Lateral distance between the heel centre of
one foot to the line of progression of the
other side.
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ference in disability, for the purpose of our analysis, we
defined the following groups: EDSS score 1.0 and 1.5 in
one group, and similarly EDSS 2.0-2.5, EDSS 3.0-3.5 as
well as EDSS 4.0-4.5 and EDSS 5.0-5.5 into separate
groups. Since there is a major difference between EDSS
6.0 and 6.5 (unilateral versus bilateral walk aid), these
groups are analysed as two separate levels of disability.
Statistics
Descriptive statistics were used to characterize the popu-
lation. The Kolmogorov-Smirnov test for independent
samples was used to test for normality of the distribu-
tion in all parameters. As a result, GaitRite provides
more than 40 variables for each leg and a number of
these variables are related one to another. Therefore, to
find relevant measurements in order to assess the extent
of gait impairment and to avoid multiple comparisons,
we have first applied simple pre-selection stage. The
Pearson correlation coefficient was used to identify
highly correlated measurements (r > 0.9) and to select
representative variables for further analyses.
Subsequently, a two-way repeated measures analysis of
covariance (ANCOVA) was used to assess the effect of
factors involving Group (EDSS 0–1.5, 2.0-2.5, 3.0-3.5,
4.0-4.5, 5.0-5.5, 6, 6.5) and Walking (SW, FW), and in-
teractions between these two factors, with age and leg
length set as covariates. Post-hoc Bonferroni adjustment
was then applied to determine differences between indi-
vidual EDSS groups and walking conditions. A nominal
alpha level of 0.05 was used for all comparisons. The
main effects and interactions resulting from ANCOVA
were interpreted as follows: (a) a main effect of Group
(meaning EDSS group) is statistically significant if there
is difference in patients' performance across individual
EDSS groups, i.e. patients with higher EDSS scores gen-
erally reached worse performance than those with lower
EDSS scores; (b) a main effect of Walking (SW versus
FW) is statistically significant if the measured parameter
reflects speed of walking; (c) an interaction involving
Group x Walking is statistically significant if the mea-
sured parameter is dependent on the speed of walking,
i.e. difference between fast and normal speed of walking.
Post-hoc comparisons were used to evaluate whether the
individual EDSS groups can be separated across tested
parameters.
Results
The Kolmogorov-Smirnov test indicated that gait vari-
ables were normally distributed across EDSS groups.
Using Pearson correlation, we have identified five repre-
sentative variables including velocity, step length, step
time, double support time, and base width; the correl-
ation coefficient between these variables was not greaterthan 0.9 (r = 0.12–0.88, p < 0.01). Since the results of the
left and right leg for investigated variables were highly
correlated (r = 0.91–0.96, p < 0.001), we further analysed
data based only on the left leg. In addition, when applic-
able, the variability of investigated parameters were also
included in the analyses (i.e., step length SD, step time
SD, and support base SD). The description of variables
used in the current study can be found in Table 2. The
results for the seven EDSS groups in both walking con-
ditions (SW, FW) across each investigated parameter are
interpreted using mean ± SD (Table 3) as well as box-
plots (Figure 1). In addition, Table 4 lists mean ± SD of
the variability of gait parameters.
Velocity
Velocity of gait significantly decreased with increasing
disability level during both SW and FW tests. Results of
the ANCOVA for velocity showed significant main ef-
fects for Group [F(6, 569) = 126.1, p < 0.001, η2 = 0.58]
and Walking [F(1, 569) = 280.5, p < 0.001, η2 = 0.34], as
well as a significant interaction effect for Group ×Walking
[F(6, 569) = 11.1, p < 0.001, η2 = 0.11]. Post-hoc compari-
sons revealed significant differences between any two con-
secutive disability groups through EDSS 2.0 to 6.5 (2.0-2.5
vs. 3.0-3.5: p = 0.001; 3.0-3.5 vs. 4.0-4.5: p = 0.005; 4.0-4.5
vs. 5.0-5.5: p = 0.001; 5.0-5.5 vs. 6.0: p < 0.001; 6.0 vs. 6.5:
p = 0.046). The differences in velocity between the two
lowest Groups (EDSS 0–1.5 vs. 2.0-2.5) did not reach stat-
istical significance. The difference in velocity between SW
and FW continuously diminished with increasing disabil-
ity. There was no difference in velocity between SW and
FW at EDSS 6.5.
Step length
Step length significantly decreased with increasing dis-
ability when comparing between any two consecutive
Groups from EDSS 0 to 6.0 in both SW and FW. There
was no significant difference in step length between
Table 3 Gait parameters across EDSS levels
EDSS levels Walking conditions Velocity (cm/s) Step length (cm) Step time (s) Double support time (%) Base width (cm)
0-1.5 Normal 124.9 ± 17.3 67.7 ± 6.4 0.54 ± 0.05 25.2 ± 2.8 9.3 ± 2.6
Fast 182.6 ± 24.6 79.6 ± 8.2 0.43 ± 0.04 19.5 ± 3.1 9.2 ± 2.5
2.0-2.5 Normal 120.8 ± 17.6 67.4 ± 7.1 0.55 ± 0.05 25.6 ± 3.3 10.2 ± 2.9
Fast 178.4 ± 25.5 79.0 ± 9.3 0.45 ± 0.08 20.2 ± 3.3 9.8 ± 3.1
3.0-3.5 Normal 112.7 ± 16.0 62.2 ± 6.8 0.55 ± 0.04 27.1 ± 3.1 9.8 ± 3.2
Fast 155.3 ± 29.9 72.4 ± 8.8 0.47 ± 0.06 21.6 ± 3.7 9.8 ± 3.0
4.0-4.5 Normal 103.4 ± 19.0 58.5 ± 6.4 0.57 ± 0.07 29.4 ± 3.9 11.1 ± 4.1
Fast 139.6 ± 25.4 67.3 ± 7.1 0.49 ± 0.07 25.1 ± 4.5 11.3 ± 3.9
5.0-5.5 Normal 85.5 ± 18.5 52.9 ± 7.8 0.63 ± 0.09 34.2 ± 5.5 12.1 ± 4.3
Fast 109.9 ± 24.5 58.5 ± 7.3 0.55 ± 0.08 29.8 ± 5.0 11.6 ± 5.2
6.0 Normal 57.3 ± 19.1 43.5 ± 9.0 0.82 ± 0.23 41.2 ± 8.0 12.2 ± 6.0
Fast 79.5 ± 50.8 ± 10.4 0.73 ± 0.24 35.6 ± 9.5 12.2 ± 5.5
6.5 Normal 47.5 ± 24.4 45.0 ± 11.3 1.09 ± 0.46 48.4 ± 14.9 11.0 ± 5.9
Fast 58.2 ± 26.7 49.4 ± 11.9 0.95 ± 0.36 44.6 ± 13.5 11.4 ± 4.7
Overall Normal 104.8 ± 30.4 60.4 ± 11.0 0.62 ± 0.19 29.8 ± 8.4 10.5 ± 3.9
Fast 148.4 ± 47.2 70.4 ± 13.8 0.52 ± 0.18 24.6 ± 8.8 10.4 ± 3.8
The results are expressed as mean ± SD.
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significant main effects for Group [F(6, 569) = 91.0,
p < 0.001, η2 = 0.50] and Walking [F(1, 569) = 138.1,
p < 0.001, η2 = 0.20], as well as a significant interaction
effect for Group ×Walking [F(6, 569) = 2.6, p = 0.02,
η2 = 0.03]. Post-hoc comparisons revealed significant dif-
ferences between EDSS groups 2.0-6.0 (2.0-2.5 vs. 3.0-
3.5: p = 0.001; 3.0-3.5 vs. 4.0-4.5: p = 0.002; 4.0-4.5 vs.
5.0-5.5: p = 0.01; 5.0-5.5 vs. 6.0: p < 0.001). There were
no significant differences between the two lowest and
between the two highest Groups (EDSS 0–1.5 vs. 2.0-2.5
and 6.0 vs. 6.5). Only at EDSS 6.5 there was no signifi-
cant difference in step length between FW and SW.
Statistical analysis of step length SD (indicating vari-
ability of step length) revealed a significant main effects
for Group [F(6, 569) = 32.7, p < 0.001, η2 = 0.09] and
Walking [F(1, 569) = 19.1 p = 0.02, η2 = 0.01], as well as a
significant interaction for Group ×Walking [F(6, 569) =
5.3, p = 0.02, η2 = 0.03]. Post-hoc comparisons revealed
significant differences only between two consecutive
EDSS groups 4.0-4.5 vs. 5.0-5.5 (p = 0.003).
Step time
Step time was significantly shorter when comparing any
two consecutive Groups between EDSS 5.0 to 6.5 in
both SW and FW, but not for patients with EDSS below
5.0. There was no significant difference in step time be-
tween FW versus SW in patients who reached EDSS 6.0
and 6.5. Step time showed significant main effects for
Group [F(6, 569) = 79.8, p < 0.001, η2 = 0.46] and Walking[F(1, 569) = 61.9, p < 0.001, η2 = 0.10], but no significant
interaction for Group ×Walking [F(6, 569) = 0.3, p = 0.96,
η2 = 0]. Post-hoc analysis showed no significant differences
in step time within EDSS 0–5.5, while there is high statis-
tically significant difference between groups with EDSS
5.0-6.5 (5.0-5.5 vs. 6.0: p < 0.001; 6.0 vs. 6.5: p < 0.001).
Statistical analysis of step time SD (indicating variabil-
ity of step time) showed significant main effects for
Group [F(6, 569) = 6.0, p < 0.001, η2 = 0.06] but no sig-
nificant effect for Walking [F(1, 569) = 0.3, p = 0.56,
η2 = 0] or interaction Group ×Walking [F(6, 569) = 1.2,
p = 0.37, η2 = 0.01]. Post-hoc analysis did not revealed any
significant differences between two consecutive groups.Percentage of double support time
The percentage of double support time is increased in
patients with higher disability score, when comparing
any two consecutive Groups from EDSS 4.0 to 6.5 in
both SW and FW, but not for patients with EDSS below
4.0. Analysis of the double support time showed signifi-
cant main effects for Group [F(6, 569) = 102.6, p < 0.001,
η2 = 0.53] and Walking [F(1, 569) = 93.7, p < 0.001,
η2 = 0.15], but no significant interaction for Group ×
Walking [F(6, 569) = 0.3, p = 0.94, η2 = 0]. Post-hoc ana-
lysis revealed significant differences in moderate-to-
higher EDDS groups (3.0-3.5 vs. 4.0-4.5: p = 0.02; 4.0-4.5
vs. 5.0-5.5: p = 0.02; 5.0-5.5 vs. 6.0: p < 0.001; 6.0 vs. 6.5:
p < 0.001), whereas no significant differences were found
between low-to-moderate EDSS levels (0–3.5).
Figure 1 Comparison of gait measures for self-selected and fast walk speed across different EDSS levels.
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Patients with higher EDSS scores generally did not have
significantly increased base width. Statistical analysis
showed significant effect for Group [F(6, 569) = 4.8,
p < 0.001, η2 = 0.05], but not for Walking [F(1, 569) =
0.01, p = 0.91, η2 = 0] or the interaction Group ×Walking
[F(6, 569) = 0.12, p = 0.99, η2 = 0]. However, post-hoc
analysis did not revealed any significant differences be-
tween two consecutive groups.
Statistical analysis of base width SD (for variability of
base width) showed significant effect for Group [F(6,
569) = 13.3, p < 0.001, η2 = 0.06], but not for Walking
[F(1, 569) = 0.11, p = 0.74, η2 = 0] or the interactions
Group ×Walking [F(6, 569) = 1.0, p = 0.41, η2 = 0.1].
Post-hoc analysis did not revealed any significant differ-
ences between two consecutive groups.Discussion
In this study of 284 MS subjects with EDSS 0 – 6.5, we fo-
cused on analysis of the gait cycle to understand changes
that occur at different levels of disability and how these pa-
rameters could be used as outcome measures. The decrease
in step length is a phenomenon observed at EDSS levels
0–6.0 that reaches a plateau between EDSS 6.0 and 6.5.
The other phenomenon we observed is the prolonga-
tion of the step time, which reached significance at EDSS
5.0 and higher. The velocity at EDSS 6.0 and 6.5 is sig-
nificantly lower, however the step length remained con-
stant. The extra portion of the step time is spent in the
double support phase of the gait cycle. The increase in
percentage of double support time becomes statistically
significant at EDSS 3.0-3.5 and continues to increase in
all groups until EDSS 6.5.
Table 4 Variability of gait measures across EDSS levels
EDSS levels Walking conditions Step length variability (cm) Step time variability (ms) Base width variability (cm)
0-1.5 Normal 2.5 ± 1.4 20.4 ± 12.2 2.06 ± 0.94
Fast 2.8 ± 1.5 20.3 ± 16.5 2.12 ± 1.05
2.0-2.5 Normal 2.7 ± 1.5 20.4 ± 14.5 2.13 ± 1.03
Fast 3.2 ± 1.8 38.2 ± 13.2 2.13 ± 1.15
3.0-3.5 Normal 2.7 ± 1.4 23.5 ± 18.7 2.13 ± 1.03
Fast 3.0 ± 1.3 28.9 ± 82.9 2.83 ± 1.53
4.0-4.5 Normal 2.9 ± 1.2 30.5 ± 30.6 2.98 ± 1.75
Fast 3.0 ± 1.4 37.7 ± 116.9 2.83 ± 1.31
5.0-5.5 Normal 4.1 ± 2.5 43.3 ± 31.6 2.98 ± 1.52
Fast 4.4 ± 2.5 33.0 ± 25.3 3.38 ± 2.36
6.0 Normal 4.8 ± 3.5 93.8 ± 106.1 3.51 ± 3.26
Fast 3.9 ± 2.0 58.0 ± 47.9 3.15 ± 2.72
6.5 Normal 3.0 ± 0.8 86.4 ± 72.1 2.81 ± 1.28
Fast 5.4 ± 5.2 74.5 ± 58.9 2.50 ± 1.19
Overall Normal 3.0 ± 1.9 35.2 ± 48.8 2.48 ± 1.62
Fast 3.3 ± 2.1 36.5 ± 90.1 2.55 ± 1.60
The results are expressed as mean ± SD.
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study, assessing it at individual EDSS levels had shown
interesting observations. Patients with EDSS 0–3.5 are
all defined as fully ambulatory by EDSS definition, how-
ever patients at EDSS3.0-3.5 walk significantly slower
than patients with EDSS 0–1.5 and 2.0-2.5. When com-
paring velocity at SW versus FW, we observed that pa-
tients with EDSS 3–3.5 had a significantly lower capacity
to increase velocity between SW and FW than patients
with EDSS 0–1.5 and 2.0- 2.5 (Figure 1). This phenomenon
is even more revealing in patients with higher EDSS levels.
Velocity of patients with EDSS 6.0 at SW was about half of
the velocity of patients with EDSS 3.0 -3.5 (57 cm/s vs.
112 cm/s). The difference in velocity between FW and SW
at EDSS 3.0-3.5 was 43 cm/s, while patients with EDSS 6.0
were able to increase their speed only by 22 cm/s. Thus,
patients with higher EDSS levels were not only walking
slower, but their velocity at SW was much closer to their
maximal speed of walking than in patients with lower
EDSS. Patients at EDSS 6.5 seem to be unable to increase
the speed between SW and FW tests, so they walk at their
maximal speed of walking at all times (Figure 1). The rela-
tionship between SW and FW in MS has not been widely
studied, as MS studies use mostly fast walk tests. However,
Van der Linden et al. had shown that MS patients walking
at self selected speed had reduced dorsiflexion at initial
contact with the floor, reduced plantar flexion and reduced
knee flexion in swing phase as the possible mechanisms of
speed decline in MS [16]. When we compare the velocity
of patients in our study to the data from meta analysis ofnormal speed of gait by Bohannon, the velocity of 112.67 ±
15.95 cm/s reached at SW by patients with EDSS 3.0-3.5
(mean age 38.7, SD 9.1) corresponds to a self selected speed
of gait typical in the normal population for women in the
seventh decade (113.2 cm/s (range 107.2 to 119.2) [17].
Whereas our dataset is focused on assessment of gait
characteristics at individual EDSS levels, the results are
in general agreement with prior studies of gait abnor-
malities in MS, such as of Givon et al., who studied
group of 81 independently walking MS patients (mean
EDSS 2.8, range 0–5.5) and documented that these pa-
tients walked slower, used shorter steps, had longer step
time than normal controls and the gait parameters cor-
related strongly with EDSS scores [18]. Sosnoff et al.,
had also shown the prolongation of double support time
in 13 MS patients with EDSS 4.0-6.0 compared with
normal controls [19]. Soccie et al. in 2012 had shown in
a study that focused on gait variability in MS (N = 88)
that individuals who used assistive devices for ambu-
lation (EDSS 6.0-6.5) had significantly lower velocity of
gait and shorter step length than independent walkers
(EDSS 2.0-5.5) [20].
We did not find statistical difference in the base width
across the EDSS levels. Prior studies have demonstrated
that MS patients in general have wider base of gait than
normal controls, however they did not show significant
correlation between EDSS and base width [20]. Contrary
to that, Balantrapu et al. have observed that patients
with higher EDSS have more spasticity, which correlated
with a decrease in base width [21]. We did not evaluate
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sing the role of spasticity in base width.
Investigation of variability of gait, measured as step to
step variation, did not reveal any significant difference
between the EDSS levels. Stride to stride variation was
shown to correlate with disease severity and response to
treatment in diseases that involve basal ganglia (such as
Parkinson disease and Morbus Huntington) [22]. Vari-
ability of gait in multiple sclerosis measured using GAI-
TRite walkway over a short distance is not significant.Conclusions
This study elucidated how the temporal and spatial pa-
rameters of gait change across the levels of disability from
EDSS 0 to 6.5. It is obvious that there is no single param-
eter (other than velocity of gait) that could be used to
measure changes at all levels of disability. However, there
are different parameters involved in velocity loss at differ-
ent EDSS levels. The step length shortens significantly at
EDSS 2.0 to 6.0, and percentage of double support time is
significantly prolonged at EDSS 3.0 – 6.5. The shortening
of step length plateaus at EDSS 6.0 – 6.5. Parameter that
does not differ between EDSS 6.0 and 6.5 will not be use-
ful outcome to measure gait changes at those levels. The
cross-sectional nature of the study limits us in under-
standing how these variables would change in individual
patients with progression of EDSS over time. Evaluation of
walking at SW and FW in the same setting had shown us
that the fast speed of walking is more sensitive to detect-
ing patient’s deficits. These facts have to be considered
when designing gait experiments with temporal and
spatial parameters of gait as outcome measures.
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